These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9717063)

  • 1. Angiographic evidence for the role of triglyceride-rich lipoproteins in progression of coronary artery disease.
    Thompson GR
    Eur Heart J; 1998 Jul; 19 Suppl H():H31-6. PubMed ID: 9717063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenicity of triglyceride-rich lipoproteins.
    Krauss RM
    Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
    Steiner G; Schwartz L; Shumak S; Poapst M
    Circulation; 1987 Jan; 75(1):124-30. PubMed ID: 3791598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ; Campos H; Moye LA; Sacks FM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):853-8. PubMed ID: 12637336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.
    Mack WJ; Krauss RM; Hodis HN
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):697-704. PubMed ID: 8963728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride-rich lipoproteins and progression of atherosclerosis.
    Hodis HN; Mack WJ
    Eur Heart J; 1998 Feb; 19 Suppl A():A40-4. PubMed ID: 9519342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease.
    Lipinska I; Gurewich V; Meriam CM; Kosowsky BD; Ramaswamy K; Philbin E; Losordo D
    Artery; 1987; 15(1):44-60. PubMed ID: 3435252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides and atherogenic lipoproteins: rationale for lipid management.
    Krauss RM
    Am J Med; 1998 Jul; 105(1A):58S-62S. PubMed ID: 9707269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein and apoprotein values in coronary angiography patients.
    Kladetzky RG; Assmann G; Walgenbach S; Tauchert P; Helb HD
    Artery; 1980; 7(3):191-205. PubMed ID: 7469794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride-rich lipoproteins and the progression of coronary artery disease.
    Hodis HN; Mack WJ
    Curr Opin Lipidol; 1995 Aug; 6(4):209-14. PubMed ID: 7670749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.